Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy

Structural immunology, focusing on structures of host immune related molecules, enables the immunologists to see what the molecules look like, and more importantly, how they work together. Antibody-based PD-1/PD-L1 blockade therapy has achieved brilliant successes in clinical applications. The recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Shuguang, Zhang, Catherine W-H, Gao, George F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661648/
https://www.ncbi.nlm.nih.gov/pubmed/29263905
http://dx.doi.org/10.1038/sigtrans.2016.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661648/
https://www.ncbi.nlm.nih.gov/pubmed/29263905
http://dx.doi.org/10.1038/sigtrans.2016.29

Ejemplares similares